David J Ballance

Title: Innovations of David J Ballance

Introduction

David J Ballance is a notable inventor based in Attenborough, GB. He has made significant contributions to the field of biotechnology, holding a total of three patents. His work focuses on innovative methods that have the potential to impact cellular processes.

Latest Patents

One of his latest patents is titled "Modulation of cellular proliferation with thymidine phosphorylase." This patent describes a method of modulating cellular proliferation by applying thymidine phosphorylase to an organism. The method includes a conjugate that targets specific cell types or anatomical locations. The thymidine phosphorylase exhibits an activity level of at least about 5%, with preferred levels of at least about 50% and most preferably at least about 90% of the native enzyme. Another significant patent involves "Polypeptides," which details a fusion polypeptide that includes an N-terminal portion of human serum albumin (HSA) or a variant thereof, along with a C-terminal portion that is another specified polypeptide. This innovation may facilitate the secretion of the polypeptide from host cells.

Career Highlights

David J Ballance is currently associated with Delta Biotechnology Limited, where he continues to advance his research and development efforts. His work at the company reflects his commitment to pushing the boundaries of biotechnology.

Collaborations

He has collaborated with notable coworkers, including Andrew Robert Goodey and Edward Hinchliffe, contributing to a dynamic research environment.

Conclusion

David J Ballance's innovative work in biotechnology, particularly in cellular modulation and polypeptide development, showcases his significant contributions to the field. His patents reflect a dedication to advancing scientific knowledge and practical applications in medicine.